Search
SOLACI Congress
HomeFile

File

View Category
Sponsored Symposia

SOLACI-CACI 2021 | Current Controversies in Post-TAVR CORONARY ACCESS – Medtronic Symposium

✔️ MEDTRONIC Symposium in the SOLACI-CACI 2021 Virtual Congress.✔️ Topic: Current Controversies in Post-TAVR CORONARY ACCESS.  👨‍🏫 Program:...
solaci -
Learn More
Coronary disease

SOLACI-CACI 2021 | SELUTION SLR DEB – Changing the Treatment Paradigm for Complex Lesions – Medalliance Symposium

✔️ MEDALLIANCE Symposium in the SOLACI-CACI 2021 Virtual Congress.✔️ Topic: SELUTION SLR DEB – Changing the Treatment...
solaci -
Learn More
Coronary disease

SOLACI-CACI 2021 | Using the MLD MAX Algorithm in OCT-Guided PERCUTANEOUS CORONARY INTERVENTIONS – ABBOTT Symposium

✔️ Watch again the ABBOTT Symposium in the SOLACI-CACI 2021 Virtual Congress. ✔️ Topic: Using the MLD...
solaci -
Learn More
Coronary disease

SOLACI-CACI 2021 | Overcoming Challenges of the BALLOON EXPANDABLE TAVI Cases – EDWARDS Symposium

✔️ Watch again the Edwards Lifesciences Symposium in the SOLACI-CACI 2021 Virtual Congress.✔️ Topic: Overcoming Challenges of...
solaci -
Learn More
Coronary disease

SOLACI-CACI 2021 | PCI image guidance and robotic automation for precise treatment – Siemens Healthineers Symposium

✔️ Watch again the SIEMENS HEALTHINEERS Symposium at the SOLACI-CACI 2021 Virtual Congress.✔️ Topic: PCI image guidance...
solaci -
Learn More
Antiplatelet

Can Ticagrelor Prevent Strokes in High-Risk Patients?

In addition to aspirin, Ticagrelor offers better prognosis in patients that already had a stroke and have...
solaci -
Learn More
Antiplatelet

ESC 2021 | ENVISAGE-TAVI AF: Surprise with Endoxaban in TAVR and Atrial Fibrillation

The enthusiasm for direct oral anticoagulants after transcatheter aortic valve replacements (TAVR) is waning. At least, when...
solaci -
Learn More
Antiplatelet

HOST-EXAM: The Study that Challenges Aspirin as Long-Term Antiplatelet Therapy

The HOST-EXAM study (which was prospective, randomized, and open-label, with the participation of 37 Korean sites) was specifically...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition

solaci - 0
Registration is now open for the SOLACI–CACI Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition. The program is intended for physicians with...

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy